These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 16156677)

  • 101. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

  • 102. Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
    Robakis D; Fahn S
    CNS Drugs; 2015 Jun; 29(6):433-41. PubMed ID: 26164425
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Dopamine agonists in Parkinson's disease therapy - 15 years of experience of the Neurological Clinics from Tîrgu Mureș. A cross-sectional study].
    Szász JA; Viorelia C; Mihály I; Biró I; Péter C; Orbán-Kis K; Szatmári S
    Ideggyogy Sz; 2019 May; 72(5-6):187-193. PubMed ID: 31241263
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Motor fluctuations in Parkinson's disease: pathophysiology and treatment.
    Colosimo C; De Michele M
    Eur J Neurol; 1999 Jan; 6(1):1-21. PubMed ID: 10209344
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Initiation of pharmacological therapy in Parkinson's disease: when, why, and how.
    de Bie RMA; Clarke CE; Espay AJ; Fox SH; Lang AE
    Lancet Neurol; 2020 May; 19(5):452-461. PubMed ID: 32171387
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Treatment of early Parkinson's disease. Part 1.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):193-205. PubMed ID: 19176960
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [The new Parkinson's disease drugs].
    Hasegawa K
    Nihon Rinsho; 2000 Oct; 58(10):2066-71. PubMed ID: 11068448
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Treatment of motor symptoms in Parkinson's disease].
    Morís-De la Tassa G; Arias-Rodríguez M
    Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Update on Current Care Guideline: Parkinson's disease].
    Pekkonen E; Atula S; Autere J; Eerola-Rautio J; Kaasinen V; Kauppinen M; Martikainen K; Ruottinen H; Viljamaa M
    Duodecim; 2016; 132(1):91-3. PubMed ID: 27044185
    [TBL] [Abstract][Full Text] [Related]  

  • 111. How should we treat a patient with early Parkinson's disease?
    Tsouli S; Konitsiotis S
    Int J Clin Pract; 2010 Aug; 64(9):1210-9. PubMed ID: 20653797
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [Medical treatment of Parkinson's disease in elderly and multimorbid patients].
    Lettow I; Röther J
    Internist (Berl); 2014 Jun; 55(6):728-34. PubMed ID: 24806271
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Levodopa versus levodopa sparing in early parkinson's disease: can we meet halfway?
    Rodríguez-Violante M; Hernández-Medrano AJ; Cervantes-Arriaga A; Torres-Vásquez C; Tristán-Samaniego D; Zepeda-Salazar C; Cerino-Palomino V; Abundes-Corona A
    Rev Invest Clin; 2024 Jul; 76(3):133-144. PubMed ID: 39028854
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Dopamine agonists.
    Tuite P; Ebbitt B
    Semin Neurol; 2001; 21(1):9-14. PubMed ID: 11346030
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Initial choice of medication has little effect on short-term or long-term outcome for most patients with Parkinson's disease.
    Hauser RA
    Evid Based Med; 2015 Feb; 20(1):17. PubMed ID: 25525039
    [No Abstract]   [Full Text] [Related]  

  • 116. Long-term studies of dopamine agonists.
    Hubble JP
    Neurology; 2002 Feb; 58(4 Suppl 1):S42-50. PubMed ID: 11909984
    [TBL] [Abstract][Full Text] [Related]  

  • 117. When should levodopa therapy be initiated in patients with Parkinson's disease?
    Halkias IA; Haq I; Huang Z; Fernandez HH
    Drugs Aging; 2007; 24(4):261-73. PubMed ID: 17432922
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
    Pirker W; Katzenschlager R; Hallett M; Poewe W
    J Parkinsons Dis; 2023; 13(2):127-144. PubMed ID: 36847017
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.
    Gallagher DA; Schrag A
    CNS Drugs; 2008; 22(7):563-86. PubMed ID: 18547126
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A Real-Life Search for the Optimal Set of Conversion Factors to Levodopa-Equivalent-Dose in Parkinson's Disease Patients on Polytherapy.
    Snineh MA; Hajyahya A; Linetsky E; Eitan R; Bergman H; Israel Z; Arkadir D
    J Parkinsons Dis; 2020; 10(1):173-178. PubMed ID: 31868682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.